mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation

Detalles Bibliográficos
Autores principales: Osada, Naoki, Kikuchi, Jiro, Koyama, Daisuke, Kuroda, Yoshiaki, Yasui, Hiroshi, Leverson, Joel D., Furukawa, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561283/
https://www.ncbi.nlm.nih.gov/pubmed/34261294
http://dx.doi.org/10.3324/haematol.2021.278506
_version_ 1784593088366247936
author Osada, Naoki
Kikuchi, Jiro
Koyama, Daisuke
Kuroda, Yoshiaki
Yasui, Hiroshi
Leverson, Joel D.
Furukawa, Yusuke
author_facet Osada, Naoki
Kikuchi, Jiro
Koyama, Daisuke
Kuroda, Yoshiaki
Yasui, Hiroshi
Leverson, Joel D.
Furukawa, Yusuke
author_sort Osada, Naoki
collection PubMed
description
format Online
Article
Text
id pubmed-8561283
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-85612832021-11-10 mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation Osada, Naoki Kikuchi, Jiro Koyama, Daisuke Kuroda, Yoshiaki Yasui, Hiroshi Leverson, Joel D. Furukawa, Yusuke Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-07-15 /pmc/articles/PMC8561283/ /pubmed/34261294 http://dx.doi.org/10.3324/haematol.2021.278506 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letters to the Editor
Osada, Naoki
Kikuchi, Jiro
Koyama, Daisuke
Kuroda, Yoshiaki
Yasui, Hiroshi
Leverson, Joel D.
Furukawa, Yusuke
mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation
title mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation
title_full mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation
title_fullStr mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation
title_full_unstemmed mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation
title_short mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3- and Blimp-1-mediated BCL-2 upregulation
title_sort mtor inhibitors sensitize multiple myeloma cells to venetoclax via ikzf3- and blimp-1-mediated bcl-2 upregulation
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561283/
https://www.ncbi.nlm.nih.gov/pubmed/34261294
http://dx.doi.org/10.3324/haematol.2021.278506
work_keys_str_mv AT osadanaoki mtorinhibitorssensitizemultiplemyelomacellstovenetoclaxviaikzf3andblimp1mediatedbcl2upregulation
AT kikuchijiro mtorinhibitorssensitizemultiplemyelomacellstovenetoclaxviaikzf3andblimp1mediatedbcl2upregulation
AT koyamadaisuke mtorinhibitorssensitizemultiplemyelomacellstovenetoclaxviaikzf3andblimp1mediatedbcl2upregulation
AT kurodayoshiaki mtorinhibitorssensitizemultiplemyelomacellstovenetoclaxviaikzf3andblimp1mediatedbcl2upregulation
AT yasuihiroshi mtorinhibitorssensitizemultiplemyelomacellstovenetoclaxviaikzf3andblimp1mediatedbcl2upregulation
AT leversonjoeld mtorinhibitorssensitizemultiplemyelomacellstovenetoclaxviaikzf3andblimp1mediatedbcl2upregulation
AT furukawayusuke mtorinhibitorssensitizemultiplemyelomacellstovenetoclaxviaikzf3andblimp1mediatedbcl2upregulation

Ejemplares similares